Understand the markers and symptoms that indicate disease activity and monitor them over time.
Several biomarkers help your care team assess IBD activity. Fecal calprotectin is one of the most useful — it measures inflammation directly in the gut and is collected non-invasively through a stool sample. C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) are blood tests that reflect systemic inflammation.
Each marker has strengths and limitations. Calprotectin is highly specific to gut inflammation, while CRP can be elevated by other conditions. Understanding what your results mean — and how they trend over time — gives you a clearer picture of your disease activity between scopes.
A single lab result is just a snapshot. What matters most is the trend. Is your calprotectin rising, falling, or stable? A value of 200 might be concerning if your previous reading was 50, but reassuring if it's come down from 800.
Keep a log of your lab results alongside your symptoms, treatments, and life events. Over time, you'll start to see patterns that help you and your doctor make proactive decisions rather than reactive ones. Many patients find that tracking gives them a sense of control over an unpredictable condition.
While lab markers are valuable, they don't tell the whole story. Symptoms like fatigue, urgency, and abdominal pain are important indicators too. Some patients have elevated markers with minimal symptoms, while others feel terrible with normal labs — a phenomenon sometimes called a "clinical-biochemical disconnect."
The best approach combines objective markers with your subjective experience. Report your symptoms honestly to your care team, and don't dismiss how you feel just because a lab result looks acceptable. Your lived experience is a crucial part of the clinical picture.
This content is for educational purposes only and is not a substitute for professional medical advice. Always consult with your healthcare provider about your individual care.